排序方式: 共有105条查询结果,搜索用时 15 毫秒
101.
Farshad Malihi Azadeh Hosseini-Tabatabaei Hadi Esmaily Reza Khorasani Maryam Baeeri Mohammad Abdollahi 《Central European Journal of Biology》2009,4(3):369-380
Type 1 diabetes mellitus (T1DM) is characterized by an impairment of the insulin-secreting beta cells with an immunologic
base. Inflammatory cytokines such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β, and free radicals are believed
to play key roles in destruction of pancreatic β cells. The present study was designed to investigate the effect of Silybum marianum seed extract (silymarin), a combination of several flavonolignans with immunomodulatory, anti-oxidant, and anti-inflammatory
potential on streptozotocin (STZ)-induced T1DM in mouse. Experimental T1DM was induced in male albino mice by IV injection
of multiplelow- doses of STZ for 5 days. Seventy-two male mice in separate groups received various doses of silymarin (20,
40, and 80 mg/kg) concomitant or after induction of diabetes for 21 days. Blood glucose and pancreatic biomarkers of inflammation
and toxic stress (IL-1β, TNF-α, myeloperoxidase, lipid peroxidation, protein oxidation, thiol molecules, and total antioxidant
capacity) were determined. Silymarin treatment reduced levels of inflammatory cytokines such as TNF-α and IL-1β and oxidative
stress mediators like myeloperoxidase activity, lipid peroxidation, carbonyl and thiol content of pancreatic tissue in an
almost dose dependent manner. No marked difference between the prevention of T1DM and the reversion of this disease by silymarin
was found. Use of silymarin seems to be helpful in T1DM when used as pretreatment or treatment. Benefit of silymarin in human
T1DM remains to be elucidated by clinical trials. 相似文献
102.
103.
Nahid Shahabadi Saba Hadidi Farshad Shiri 《Journal of biomolecular structure & dynamics》2020,38(1):283-294
AbstractCommunicated by Ramaswamy H. Sarma 相似文献
104.